Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q1 2026 Earnings Call Transcript
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q1 2026 Earnings Call Transcript May 12, 2026Verrica Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.41, expectations were $-0.59.



